Literature DB >> 26017514

Migraine with aura and patent foramen ovale: myth or reality?

C Finocchi1, M Del Sette.   

Abstract

Several observational studies report that subjects with migraine with aura have a higher prevalence of right-to left shunt, commonly due to patent foramen ovale, and that patent foramen ovale is more prevalent in subjects with migraine with aura. Although migraine without aura has been less extensively studied, it does not seem to be associated with an increased prevalence of right-to left shunt. The mechanism that underlies the possible relationship between patent foramen ovale and migraine with aura remains speculative. The proposed mechanisms are migraine-triggering vasoactive chemicals bypassing the pulmonary filter and reaching the cerebral circulation and paradoxical microembolization. However, it is unclear, at this time, if there is a causal or comorbid association between the two conditions. In some families atrial shunts show a dominant inheritance that seems to be linked to inheritance of migraine with aura. Migraine with aura is an independent risk factor for ischemic stroke, and patent foramen ovale is present more frequently in patients with cryptogenic stroke than in controls. At this moment, there is no convincing evidence that excess stroke risk of migraine is simply mediated by patent foramen ovale through paradoxical embolism. Several non-controlled studies suggest that closure of the foramen ovale significantly reduces attack frequency in migraine patient, but the only prospective placebo-controlled trial does not support these results. Patent foramen ovale closure, at present, is not indicated as a treatment for migraine in clinical practice.

Entities:  

Mesh:

Year:  2015        PMID: 26017514     DOI: 10.1007/s10072-015-2163-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  42 in total

1.  Diagnosis of right-to-left shunt with transcranial Doppler and vertebrobasilar recording.

Authors:  Massimo Del Sette; Lavinia Dinia; Domenica Rizzi; Annalisa Sugo; Beatrice Albano; Carlo Gandolfo
Journal:  Stroke       Date:  2007-06-28       Impact factor: 7.914

2.  Prevalence and size of directly detected patent foramen ovale in migraine with aura.

Authors:  M Schwerzmann; K Nedeltchev; F Lagger; H P Mattle; S Windecker; B Meier; C Seiler
Journal:  Neurology       Date:  2005-09-07       Impact factor: 9.910

3.  Lack of association between migraine headache and patent foramen ovale: results of a case-control study.

Authors:  Pallav Garg; Stephen J Servoss; Justina C Wu; Zahid H Bajwa; Magdy H Selim; Alexis Dineen; Richard E Kuntz; E Francis Cook; Laura Mauri
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

4.  Patent foramen ovale in children with migraine headaches.

Authors:  Rachel T McCandless; Cammon B Arrington; Douglas C Nielsen; James F Bale; L LuAnn Minich
Journal:  J Pediatr       Date:  2011-03-30       Impact factor: 4.406

5.  Acetylsalicylic acid vs. metoprolol in migraine prophylaxis--a double-blind cross-over study.

Authors:  K H Grotemeyer; H W Scharafinski; H P Schlake; I W Husstedt
Journal:  Headache       Date:  1990-10       Impact factor: 5.887

6.  Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura.

Authors:  P T Wilmshurst; M J Pearson; S Nightingale; K P Walsh; W L Morrison
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

7.  Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients.

Authors:  M Di Tullio; R L Sacco; N Venketasubramanian; D Sherman; J P Mohr; S Homma
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

8.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

9.  Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.

Authors:  Andrew Dowson; Michael J Mullen; Richard Peatfield; Keith Muir; Arif Anis Khan; Christopher Wells; Susan L Lipscombe; Trevor Rees; Joseph V De Giovanni; W Lindsay Morrison; David Hildick-Smith; Giles Elrington; W Stewart Hillis; Iqbal S Malik; Anthony Rickards
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

10.  Compromised dynamic cerebral autoregulation in patients with a right-to-left shunt: a potential mechanism of migraine and cryptogenic stroke.

Authors:  Zhen-Ni Guo; Yingqi Xing; Jia Liu; Shuang Wang; Shuo Yan; Hang Jin; Yi Yang
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

View more
  8 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Right-to-left shunt may be prone to affect the white matter integrity of posterior circulation in migraine without aura.

Authors:  Hui Xie; Yitong Bian; Zhijie Jian; Kang Huo; Rui Liu; Dan Zhu; Lihui Zhang; Jun Wu; Jian Yang; Jixin Liu; Guogang Luo
Journal:  Neurol Sci       Date:  2017-10-23       Impact factor: 3.307

3.  Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.

Authors:  Souvik Sen; X Michelle Androulakis; Viktoriya Duda; Alvaro Alonso; Lin Yee Chen; Elsayed Z Soliman; Jared Magnani; Tushar Trivedi; Anwar T Merchant; Rebecca F Gottesman; Wayne D Rosamond
Journal:  Neurology       Date:  2018-11-14       Impact factor: 11.800

Review 4.  Patent Foramen Ovale Closure in 2019.

Authors:  Joel P Giblett; Omar Abdul-Samad; Leonard M Shapiro; Bushra S Rana; Patrick A Calvert
Journal:  Interv Cardiol       Date:  2019-02

5.  Impact of percutaneous patent foramen ovale closure on migraine headaches in patients with history of ischemic neurological events.

Authors:  Węglarz Przemysław; Katarzyna Spisak-Borowska; Tomasz Bochenek; Ewa Konarska-Kuszewska; Jerzy Machowski; Maria Trusz-Gluza; Grzegorz Bajor; Katarzyna Mizia-Stec; Joel P Giblett; Patrick A Calvert
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-10-02       Impact factor: 1.426

6.  Prevalence and grade of RLS in migraine: A prospective study of 251 migraineurs by synchronous test of c-TTE and c-TCD.

Authors:  Qiuxia Zhao; Rong Liu; Jun Zhou; Zhizhi Dong; Yue Chen
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 7.  Migraine and Stroke: What's the Link? What to Do?

Authors:  Anna Gryglas; Robert Smigiel
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

8.  Relationship between right-to-left shunt and migraine in patients with epilepsy: a single-centre, cross-sectional study in China.

Authors:  Lin Zhang; Xi Zhu; Xiangmiao Qiu; Yajiao Li; Yucheng Chen; Hui Wang; Shixu He; Wanlin Lai; Anjiao Peng; Mingming Ning; Lei Chen
Journal:  BMJ Open       Date:  2018-10-08       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.